The human immune system is one of the body’s most important defense systems. Every day, millions of immune cells move through the bloodstream and tissues looking for signs of danger.
These cells search for bacteria, viruses, and abnormal cells that could cause illness. When they find a threat, they quickly attack and destroy it. Without this powerful defense system, even common infections could become life-threatening.
However, the immune system does not always work perfectly. In some people, the system becomes confused and begins attacking the body’s own healthy tissues. When this happens, it can lead to autoimmune diseases.
These conditions include rheumatoid arthritis, lupus, and aplastic anemia. Autoimmune diseases can affect many different parts of the body, including the joints, skin, bone marrow, and internal organs.
For many years, scientists have noticed that autoimmune diseases sometimes occur alongside blood cancers such as leukemia. Doctors have seen patients who develop both conditions at the same time, but the reason behind this connection has remained a mystery.
Now, researchers at the Garvan Institute of Medical Research in Australia have uncovered an important clue.
Their new study suggests that certain genetic changes associated with leukemia can also create abnormal immune cells that attack healthy tissues. These so-called rogue immune cells may explain why cancer and autoimmune diseases sometimes appear together in the same person.
The researchers focused on a group of immune cells called T cells. T cells are a type of white blood cell that play a major role in protecting the body. Some T cells are known as killer T cells because they act like soldiers. They travel throughout the body searching for infected cells and cancer cells. Once they find a dangerous cell, they destroy it to help keep the body healthy.
Under normal conditions, killer T cells know when to stop growing and when to switch off their attack. The immune system has many built-in control systems that keep these cells balanced and prevent them from damaging healthy tissues. The new study found that certain genetic mutations can disrupt these control systems.
Instead of stopping after completing their job, some killer T cells continue to grow and multiply. Even more concerning, they may start attacking the body’s own healthy cells. This abnormal behavior can trigger autoimmune diseases and damage important tissues throughout the body.
To understand this process more clearly, the scientists studied blood samples from children with rare inherited autoimmune diseases. These rare disorders gave the researchers a valuable opportunity to observe how genetic changes can affect the immune system from an early age.
The research team also used an advanced gene-editing technology called CRISPR-Cas9. This tool allows scientists to make highly precise changes to genes. By using CRISPR in mice, the researchers were able to observe how certain mutations changed the behavior of immune cells and led to disease.
The scientists paid particular attention to a protein called STAT3. This protein helps control how immune cells grow, divide, and respond to signals from other cells. Under normal circumstances, STAT3 helps maintain a healthy balance within the immune system.
The study showed that when the STAT3 gene is altered, this balance can be lost. Killer T cells carrying the mutation become larger and much more active than normal cells. They also stop responding properly to the signals that normally regulate immune activity. In effect, these cells no longer follow the rules that keep the immune system under control.
One of the study’s most surprising findings was that only a tiny number of abnormal cells may be enough to cause serious disease. The rogue T cells accounted for only about one to two percent of all immune cells. Despite their small numbers, they were still able to trigger major autoimmune diseases.
This discovery highlights how even a small change within the immune system can have major effects on health. It also helps explain why autoimmune diseases sometimes occur in patients with blood cancers such as leukemia.
The findings may eventually lead to better treatments. Some medicines that target immune signaling pathways already exist. For example, drugs known as JAK inhibitors are currently used to treat several inflammatory diseases and have already been approved in Australia by the Therapeutic Goods Administration.
With a better understanding of how genes such as STAT3 alter immune cells, doctors may eventually be able to use these medicines in more precise and personalized ways.
The researchers also discovered new details about two groups of receptors that help immune cells respond to stress signals. These receptors allow immune cells to communicate with one another. Understanding how they work may help scientists develop new treatments that stop rogue immune cells before they cause serious damage.
Another important benefit of this research may be earlier diagnosis. In the future, advanced blood tests could allow doctors to study the immune system at a very detailed genetic level and identify abnormal immune cells before symptoms even appear. Earlier detection could give doctors a better chance to prevent serious disease or begin treatment sooner.
The study was led by Dr. Etienne Masle-Farquhar and was published in the scientific journal Immunity. The findings represent an important step toward understanding the complex relationship between leukemia and autoimmune diseases.
By revealing how small genetic changes can transform protective immune cells into harmful ones, scientists hope to develop better ways to prevent, diagnose, and treat these serious conditions in the future.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and berry that can prevent cancer, diabetes, and obesity.
For more health information, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing vitamin D supplements could strongly reduce cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
